Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by steve957on Jul 24, 2018 11:17am
87 Views
Post# 28358905

RE:RE:Prediction Here

RE:RE:Prediction Here here is a quopte from the ceo  and then my prediction

“Fundamentally, the approval of Epidiolex will have no legal impact on the sale of hemp-derived CBD for consumer goods.  The fact that the FDA has stated that they will focus on proliferation and illegal marketing of unapproved CBD-containing products with unproven medical claims is welcomed by Isodiol, stated Marcos Agramont, Isodiol International, Inc. CEO.” 

Read more at https://www.stockhouse.com/news/press-releases/2018/06/27/isodiol-international-inc-applauds-the-fdas-decision-to-recognize-the-medical#TxJEgyKFMEropMIM.99

i predict that ISOL products will not be aloud in north america, will not be able to make any claims on the labels, isol products are obselete with the FDA aprovil of Epidolex!!! I have no idea why marcos is applauding the FDA BECAUSE when epidolex was aproved isol products became usless and already in the state of california CBD from hemp it outlawed  
Bullboard Posts